Holen Sie sich die Stockscreener-App
12.79
0.62%
-0.085
Schlusskurs vom Vortag:
$12.88
Offen:
$12.75
24-Stunden-Volumen:
493.99K
Relative Volume:
0.09
Marktkapitalisierung:
$5.96B
Einnahmen:
$4.45B
Nettoeinkommen (Verlust:
$205.00M
KGV:
31.99
EPS:
0.4
Netto-Cashflow:
$372.00M
1W Leistung:
+4.23%
1M Leistung:
+55.34%
6M Leistung:
-8.44%
1J Leistung:
-24.88%
1-Tages-Spanne:
$12.67
$12.88
1-Wochen-Bereich:
$11.92
$13.21
52-Wochen-Spanne:
$8.02
$18.80
Elanco Animal Health Inc Stock (ELAN) Company Profile
Firmenname
Elanco Animal Health Inc
Sektor
Telefon
877-352-6261
Adresse
2500 INNOVATION WAY, GREENFIELD
Vergleichen Sie ELAN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
12.80 | 5.96B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
157.80 | 69.45B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.56 | 48.49B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.94 | 47.40B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.05 | 20.19B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
295.12 | 13.84B | 2.99B | 1.21B | 1.13B | 25.06 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-09 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-09-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-19 | Eingeleitet | Jefferies | Buy |
| 2023-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-04-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Sell |
| 2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-06-15 | Hochstufung | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Eingeleitet | Stifel | Buy |
| 2021-03-22 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Herabstufung | Argus | Buy → Hold |
| 2020-11-09 | Herabstufung | Barclays | Overweight → Underweight |
| 2020-08-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-08-04 | Fortgesetzt | Goldman | Buy |
| 2020-07-27 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Eingeleitet | Barclays | Overweight |
| 2019-08-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-03-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Eingeleitet | William Blair | Mkt Perform |
| 2019-01-23 | Eingeleitet | UBS | Sell |
| 2019-01-15 | Eingeleitet | Argus | Buy |
| 2018-10-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
S&P 500 Futures Drop in Premarket Trading; Dick's Sporting Goods, Elanco Animal Health Lag - Barron's
Elanco Animal Health Incorporated (NYSE:ELAN) Receives Average Recommendation of “Hold” from Brokerages - Defense World
Tylosin Market Witnessing Steady Growth in Veterinary Applications | Elanco, Huvepharma, Zoetis - openPR.com
Animal Pharmaceutical Market Expected to Expand | Key Players: Zoetis, Merck Animal Health, Elanco - openPR.com
Tower Research Capital LLC TRC Trims Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know - Yahoo Finance
What is William Blair’s Forecast for ELAN FY2025 Earnings? - Defense World
Leerink Partnrs Issues Positive Estimate for ELAN Earnings - Defense World
Elanco Animal Health (NYSE:ELAN) Price Target Raised to $15.00 - Defense World
Elanco Animal Health Incorporated Just Recorded A 117% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance
William Blair Issues Negative Forecast for ELAN Earnings - Defense World
Q2 EPS Estimate for Elanco Animal Health Reduced by Analyst - Defense World
Elanco Animal Health Incorporated (NYSE:ELAN) Q1 2025 Earnings Call Transcript - Insider Monkey
Elanco (ELAN) Stock Target Raised by Analyst Amid Favorable Quar - GuruFocus
Stifel raises Elanco stock price target to $15 from $13 - Investing.com
Elanco Animal Health (ELAN) Stock Price Target Raised by Stifel | ELAN Stock News - GuruFocus
Elanco (ELAN) Stock Target Raised by Stifel Following Strong Quarter | ELAN Stock News - GuruFocus
Elanco Animal Health Incorporated (NYSE:ELAN) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - Yahoo Finance
Elanco Animal Health First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Elanco Animal Health (NYSE:ELAN) Shares Gap Up Following Strong Earnings - Defense World
Elanco Animal Health Inc (ELAN) Q1 2025 Earnings Call Highlights: Strong Innovation Revenue and ... - Yahoo Finance
Elanco Animal Health Inc (ELAN) Q1 2025 Earnings Call Highlights: Strong Innovation Revenue and Raised Full-Year Guidance Amid Retail Challenges - GuruFocus
Why Elanco Animal Health Incorporated (ELAN) Skyrocketed On Wednesday - Insider Monkey
Decoding Elanco Animal Health Inc (ELAN): A Strategic SWOT Insig - GuruFocus
Health Care Stocks Climb As Companies Show Strong Gains - Finimize
Elanco Animal Health Shares Rise After Q1 Beat - marketscreener.com
Elanco Animal Health (ELAN) Sees Strong Q1 Performance and Raises Outlook - GuruFocus
Elanco (ELAN) Stock Trades Up, Here Is Why - Yahoo Finance
Animal Health Elanco Chirps A Solid Quarter Tempered By Soft Q2 EPS Guide - Benzinga
Elanco Animal Health (ELAN) Raises Full-Year Revenue Outlook - GuruFocus
Transcript : Elanco Animal Health Incorporated, Q1 2025 Earnings Call, May 07, 2025 - marketscreener.com
Compared to Estimates, Elanco Animal Health (ELAN) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Elanco Animal Health Inc SEC 10-Q Report - TradingView
Elanco stock spikes after Q1 beat (ELAN:NYSE) - Seeking Alpha
Elanco Animal Health Beats Q1 Estimates, Faces Revenue Growth ChallengesNews and Statistics - IndexBox
Elanco (ELAN) Beats Earnings Estimates, Raises 2025 Revenue Guidance - GuruFocus
Elanco Animal Health Incorporated (ELAN) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
Elanco Q1 2025 slides: Revenue guidance raised amid innovation-driven growth - Investing.com Canada
Elanco Animal Health beats Q1 estimates, shares rise over 3% By Investing.com - Investing.com Nigeria
Elanco Animal Health beats Q1 estimates, shares rise over 3% - Investing.com
Elanco (ELAN) Revises 2025 Revenue Forecast and Affirms Profit Projections | ELAN Stock News - GuruFocus
Elanco Animal Health Inc (ELAN) Q1 2025 Earnings: EPS of $0.13 Beats Estimate, Revenue at $1,193 Million Surpasses Expectations - GuruFocus
Elanco (NYSE:ELAN) Beats Q1 Sales Targets, Full-Year Outlook Slightly Exceeds Expectations - Yahoo Finance
Elanco (ELAN) Reports Strong Q1 Revenue with Raised 2025 Guidance | ELAN Stock News - GuruFocus
Elanco Animal Health Reports First Quarter 2025 Results | ELAN Stock News - GuruFocus
Elanco Animal Health Reports First Quarter 2025 Results - TradingView
Elanco Animal Health Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Acquired by First Trust Advisors LP - Defense World
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL.com
Companion Animal Vaccine Market Is Booming So Rapidly 2025-2032 - openPR.com
Elanco (ELAN) Reports Q1: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.47%
1.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):